Company: EDSA
Filing Date: 2025-05-28
Form Type: 8-K
Source: 0001171843-25-003495
Chunk: 0

Company: Edesa Biotech, Inc.
Filing Date: 2025-05-28
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Annual Meeting, 3,243,361 common shares, or approximately 46%
of the outstanding common shares entitled to vote, were represented by proxy or in person. The matters voted on by shareholders at the
Annual Meeting and the results of such voting are set forth below.

Proposal No. 1 - Election of the Company’s Directors

Based upon the following votes, the shareholders elected Joan Chypyha,
David Liu, Sean MacDonald, Patrick Marshall, Pardeep Nijhawan, Charles Olson and Carlo Sistilli to serve as members of the Company’s
board of directors until the annual meeting of shareholders to be held in 2026 or until their successors are duly elected and qualified.

                              For      Withhold          Broker  
                                                     Non- Votes  
 ─────────────────────────────────────────────────────────────────
  Joan Chypyha          2,242,560       155,774         845,027  
  David Liu             2,338,419        59,915         845,027  
  Sean MacDonald        2,353,931        44,403         845,027  
  Patrick Marshall      2,237,350       160,984         845,027  
  Pardeep Nijhawan      2,340,134        58,200         845,027  
  Charles Olson         2,337,266        61,068         845,027  
  Carlo Sistilli        2,342,756        55,578         845,027  

Proposal No. 2 - Advisory Vote on Executive Compensation

The shareholders approved, on an advisory basis, the executive compensation
of the named executive officers as disclosed in the proxy statement for the Annual Meeting, by the following vote.

        For      Against      Abstain      Broker Non-Votes  
 ─────────────────────────────────────────────────────────────
  2,215,325      178,016        4,993               845,027  

Proposal No. 3 - Approval of Amendment to the 2019 Equity Incentive
Compensation Plan

The shareholders approved an amendment to the Company’s 2019 Plan
to (i) increase the number of shares available for issuance thereunder plan by 1,725,000 shares, (ii) remove the 2019 Plan’s “fungible
share pool” provisions,